Enzalutamide Granted Priority Review by U.S. FDA for the Potential Treatment of Castration-Resistant Prostate Cancer in Patients Previously Treated with Chemotherapy (pdf 53KB)
Related Latest News
"Astellas Pharma Inc." more
"Pharmaceuticals" Listed Companies more
"Pharmaceuticals" Non-listed Companies more
"Tokyo" Companies more
WARNING: (1) Because this website uses a computer program to automatically collect and display press-release text information, errors or inaccuracy may occur. Double-check with information on these companies' official websites. (2) A press release may contain facts, figures and preliminary forward-looking statements which are subject to change.